12:40 IST
BSE
Board Meeting Outcome
Sudarshan Pharma Industries Board Meeting Outcome
Sudarshan Pharma's board approved migrating its equity shares from BSE SME to the Main Board. It also plans to list on the NSE Main Board.
Sudarshan Pharma Industries Ltd
- Share price
- ₹37.82
- Market cap
- ₹910.2 Cr
- Revenue (annual)
- ₹703.1 Cr
- Net profit (annual)
- ₹23.30 Cr
- P/E (TTM)
- 39.1×Sector 37.2×
- Promoter holding
- 58.93%+1.54% QoQ
- FII holding
- 19.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Date 7Share Pledge 5Other Announcement 4Financial Results 4Annual General Meeting 4Management Change 3Capital Structure Change 3Merger & Restructuring 2Fund Raise 2Acquisition 2Results Correction 1Earnings Call 1Board Meeting Outcome 1Annual Report 1
Time
1 announcement with these filters